Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2 Head & Neck 2 Other solid neoplasm 1 Gynecologic 1 Gastrointestinal 1 Dermatologic 1 Breast 1

Conditions

Triple Negative Breast Neoplasms 1 Breast Neoplasms 1

Interventions

pembrolizumab 78 Fulvestrant 76 Carboplatin 74 Trastuzumab 71 Capecitabine 69 Letrozole 62 Cyclophosphamide 61 Paclitaxel 60 pertuzumab 52 Specimen Handling 52 Docetaxel 50 abemaciclib 46 ribociclib 44 Anastrozole 35 130-nm albumin-bound paclitaxel 35 trastuzumab deruxtecan 34 Magnetic Resonance Spectroscopy 33 Blood Specimen Collection 33 Tamoxifen 32 sacituzumab govitecan 31 exemestane 31 Biopsy 31 Gemcitabine 30 Epirubicin 29 pyrotinib 28 palbociclib 28 Surveys and Questionnaires 27 Injections 27 Drug Therapy 27 eribulin 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Tiragolumab × Breast × Clear all

NCT06342037 2024-09-19

TONIC-3

The Netherlands Cancer Institute

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡